The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
AusPAR: Brexpiprazole
Australian Public Assessment Report
Device/Product Name
Rexulti
Active ingredients
Brexpiprazole
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-009095-1-1
Submission Type
New chemical entity
Decision
Approved